Septodont Septanest 4% Articaine With 1:100,000 Epinephrine
Septodont Septanest 4% Articaine With 1:100,000 Epinephrine
₹2400₹2150
10% Off
4% articaine with 1:100,000 epinephrine injection solution
Septanest 40 mg/ml plus adrenaline 0.01 mg/ml (1/100 000) is particularly appropriate for procedures of longer duration and when there is a risk of significant bleeding into the operative field.
Fast onset to avoid delay before effective analgesia is achieved.
No-methylparaben formulation to avoid allergic reactions on sensitive patients.
100% latex-free.
Terminal sterilization of product/cartridges by the Gold Standard method for Health Authorities around the world.
Milar label covered glass cartridges to minimize risk of injury in the event of a cartridge breakage.
Ensure that the cartridge and packaging are intact and not damaged before use. Discard any damaged or expired cartridges.
Select the appropriate needle and syringe for injection, ensuring that they are sterile and compatible with the cartridge.
Prepare the injection site by following proper aseptic techniques. Clean the site with an appropriate antiseptic solution.
Remove the protective cap from the cartridge, and attach the needle firmly to the syringe.
Aspirate and expel a small amount of solution to remove any air bubbles from the syringe.
Slowly and carefully insert the needle into the desired injection site, ensuring proper placement.
Aspirate again to ensure the needle is not in a blood vessel. If blood appears, remove the needle and select a new injection site.
Inject the solution slowly and steadily, taking caution not to exceed the recommended dose.
During the injection, maintain verbal contact with the patient to monitor their comfort and response.
After injection, remove the needle from the injection site and apply appropriate pressure or dressing if needed.
Properly dispose of used needles, cartridges, and other materials according to local regulations and guidelines.
Monitor the patient closely following administration, paying attention to their vital signs, potential side effects, and any adverse reactions.
Answer: Yes, Septodont Septanest 4% Articaine with 1:100,000 Epinephrine can be effective for infiltration anesthesia in managing mandibular posterior “hot tooth” cases. Infiltrative techniques, including articaine-based solutions, are commonly used for achieving successful anesthesia in challenging cases, such as those with irreversible pulpitis.
Answer: When administering Septodont Septanest 4% Articaine with 1:100,000 Epinephrine, thoroughly review the patient’s medical history and current therapies. Conduct a test injection and inject slowly, ensuring the product is not in blood vessels. Increased monitoring is necessary for patients on anticoagulants, and those with arrhythmias, coronary failure, or severe hypertension. Adjust dosage for severe hepatic insufficiency, hypoxia, hyperkalemia, or metabolic acidosis, and be mindful of potential drug interactions.
Answer: Yes, Septanest 4% Articaine should not be used in individuals with hypersensitivity or allergy to local anesthetics or any components of the formulation. It is also contraindicated in certain cardiac conditions, uncontrolled epilepsy, and porphyria. Consult with a healthcare professional for a complete list of contraindications.
Answer: Septanest 4% Articaine with 1:100,000 Epinephrine is used for local or locoregional anesthesia in dental surgery. It helps provide pain relief during dental procedures.
Answer: Septanest 4% Articaine is recommended for use in children over 4 years of age. However, the anesthesia technique may not be suitable for children under 4 years old.
Answer: Septanest 4% Articaine may interact with certain medications. It is important to inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products, to ensure there are no potential drug interactions.
Answer: Some precautions include conducting a thorough patient assessment, performing a test injection in case of allergic reactions, injecting slowly while ensuring the solution is outside blood vessels, and monitoring patients closely during and after administration. Patients under specific medical conditions or taking certain medications may require additional monitoring and dose adjustments.
July 2026
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.